http://www.laboratorytalk.com/news/lav/lav000.html Lab21 news releases on Laboratorytalk en-gb Copyright (C)2008 Pro-Talk Ltd. All rights reserved. Fri, 25 Jul 2008 08:00:00 UT Fri, 25 Jul 2008 08:00:00 UT http://www.pro-talk.com/images/protalklogo90.gif http://www.pro-talk.com/ 90 79 Lab21 now offers its newly launched K-Ras gene mutation and its epidermal growth factor receptor (EGFR) mutation testing services to its international customers Fri, 18 Jul 2008 08:00:00 UT Lab21 http://www.laboratorytalk.com/news/lav/lav119.html Provider of healthcare diagnostic products and services is expanding its cancer gene testing service and has now added an epidermal growth factor receptor (EGFR) mutation test to its existing range Thu, 26 Jun 2008 08:00:00 UT Lab21 http://www.laboratorytalk.com/news/lav/lav118.html Lab21 Environmental (UK), a provider of environmental monitoring services, is helping the Chinese government to provide safe drinking water following the earthquake in Sichuan province Wed, 25 Jun 2008 08:00:00 UT Lab21 http://www.laboratorytalk.com/news/lav/lav117.html Lab21, a provider of health and environmental diagnostics, has acquired NPTech, an independent clinical laboratory providing diagnostic testing services for the NHS and private healthcare providers Wed, 26 Mar 2008 08:00:00 UT Lab21 http://www.laboratorytalk.com/news/lav/lav116.html Amgen UK and Lab21 have announced a partnership to introduce a new genetic therapy test for advanced bowel cancer treatment in the UK Tue, 18 Mar 2008 08:00:00 UT Lab21 http://www.laboratorytalk.com/news/lav/lav115.html Lab21 has obtained a licence from Celera to provide access to its test for cirrhosis risk in patients with chronic hepatitis C viral (HCV) infection in the UK and Ireland Fri, 22 Feb 2008 08:00:00 UT Lab21 http://www.laboratorytalk.com/news/lav/lav114.html Lab21, a provider of health and environmental diagnostics, is providing a test for analysis of the K-ras gene from its Cambridge laboratories Fri, 25 Jan 2008 08:00:00 UT Lab21 http://www.laboratorytalk.com/news/lav/lav113.html Following the appointment of CEO Graham Mullis, Lab 21 is focusing its products and services under two key areas: healthcare diagnostics including personalised medicine; and environmental diagnostics Mon, 21 Jan 2008 08:00:00 UT Lab21 http://www.laboratorytalk.com/news/lav/lav112.html The oxidised low density lipoprotein (oxLDL) diagnostic test is expected to radically alter the clinical diagnosis of heart attacks in the emergency room setting Fri, 12 Oct 2007 08:00:00 UT Lab21 http://www.laboratorytalk.com/news/lav/lav111.html Agreement sees Lab21 provide operations and logistic services for the assay, which is a companion diagnostic used in the patient selection process for Pfizer's new antiretroviral treatment Celsentri Fri, 05 Oct 2007 08:00:00 UT Lab21 http://www.laboratorytalk.com/news/lav/lav110.html Newmarket Laboratories, part of the Lab21 Group, has developed a new diagnostic test for syphilis that is rapid, accurate and easy to use Wed, 15 Aug 2007 08:00:00 UT Lab21 http://www.laboratorytalk.com/news/lav/lav109.html These thrombotic tests build on Lab21's portfolio of diagnostics for personalised medicine, adding to tests for heart disease, liver disease, cystic fibrosis and Sids (sudden infant death syndrome) Mon, 25 Jun 2007 08:00:00 UT Lab21 http://www.laboratorytalk.com/news/lav/lav108.html Lab21 to market and sell Clinical Data's Familion, a genetic test designed to identify mutations in people with inherited cardiac channelopathies such as Long QT Syndrome (LQTS) and Brugada Syndrome Wed, 13 Dec 2006 08:00:00 UT Lab21 http://www.laboratorytalk.com/news/lav/lav106.html Lab 21 announces the launch of a revolutionary new assay able to detect any virus from a panel of 20 distinct respiratory viruses using multiplex detection technology Wed, 13 Dec 2006 08:00:00 UT Lab21 http://www.laboratorytalk.com/news/lav/lav107.html CD-based audiovisual presentation supports launch of liver disease assessment service and provides an overview of liver disease assessment and why it is time to review the role of liver biopsy Fri, 18 Nov 2005 08:00:00 UT Lab21 http://www.laboratorytalk.com/news/lav/lav104.html Pharmacogenetics specialis Lab21 has appointed Stephen Mathews to head up its pharmaceutical and biotech business development team Fri, 18 Nov 2005 08:00:00 UT Lab21 http://www.laboratorytalk.com/news/lav/lav105.html